0001628280-22-030745.txt : 20221123 0001628280-22-030745.hdr.sgml : 20221123 20221123160404 ACCESSION NUMBER: 0001628280-22-030745 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221121 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Donley Matthew Maxwell CENTRAL INDEX KEY: 0001636642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 221416314 MAIL ADDRESS: STREET 1: 4520 EAST WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4 1 wf-form4_166923742713580.xml FORM 4 X0306 4 2022-11-21 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001636642 Donley Matthew Maxwell #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 0 1 0 0 Ex VP, Internal Operations Common Stock 2022-11-21 4 P 0 10000 4.66 A 27927 D Includes 1,703 common stock of the Issuer acquired by the reporting person on May 31, 2022 pursuant to the Company's 2021 Employee Stock Purchase Plan. /s/ Matthew Maxwell Donley 2022-11-23